about
A Recombinant Vesicular Stomatitis Virus Ebola Vaccine — Preliminary ReportEbola virus diseaseClinical development of Ebola vaccinesEfficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)Ebola and Marburg virus vaccines.Anti-Ebola therapies based on monoclonal antibodies: current state and challenges ahead.The multifunctional Ebola virus VP40 matrix protein is a promising therapeutic target.Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lack of infection.Contrasting academic and lay press print coverage of the 2013-2016 Ebola Virus Disease outbreak.Medical research: Ebola therapy protects severely ill monkeys.Vaccines. An Ebola whole-virus vaccine is protective in nonhuman primatesEbolavirus Glycoprotein Fc Fusion Protein Protects Guinea Pigs against Lethal Challenge.Closer than ever to an Ebola virus vaccine.A Highly Conserved GEQYQQLR Epitope Has Been Identified in the Nucleoprotein of Ebola Virus by Using an In Silico Approach.Lessons learnt from the 2014 Ebola outbreak in West-Africa.Human Ebola virus infection results in substantial immune activation.A Single Dose Respiratory Recombinant Adenovirus-Based Vaccine Provides Long-Term Protection for Non-Human Primates from Lethal Ebola InfectionA Kunjin Replicon Virus-like Particle Vaccine Provides Protection Against Ebola Virus Infection in Nonhuman Primates.Adenovirus-Vectored Vaccine Provides Postexposure Protection to Ebola Virus-Infected Nonhuman Primates.Development and Characterization of Broadly Cross-reactive Monoclonal Antibodies Against All Known Ebolavirus Species.Preclinical Development of Inactivated Rabies Virus-Based Polyvalent Vaccine Against Rabies and FilovirusesMechanism of Binding to Ebola Virus Glycoprotein by the ZMapp, ZMAb, and MB-003 Cocktail Antibodies.Generation and characterization of protective antibodies to Marburg virus.Ebola Virus Infection: Overview and Update on Prevention and Treatment.A long-lasting, single-dose nasal vaccine for Ebola: a practical armament for an outbreak with significant global impactCytomegalovirus-based vaccine expressing Ebola virus glycoprotein protects nonhuman primates from Ebola virus infection.Protective efficacy of a recombinant Newcastle disease virus expressing glycoprotein of vesicular stomatitis virus in miceAntibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding SiteReverse genetics of Mononegavirales: How they work, new vaccines, and new cancer therapeuticsAnimal models for ebolavirus countermeasures discovery: what defines a useful model?Development of Small-Molecule Antivirals for Ebola.T-cell-dependent mechanisms promote Ebola VLP-induced antibody responses, but are dispensable for vaccine-mediated protection.Modeling the Disease Course of Zaire ebolavirus Infection in the Outbred Guinea Pig.Transport of Ebolavirus Nucleocapsids Is Dependent on Actin Polymerization: Live-Cell Imaging Analysis of Ebolavirus-Infected Cells.Efficacy of Vesicular Stomatitis Virus-Ebola Virus Postexposure Treatment in Rhesus Macaques Infected With Ebola Virus Makona.An Inactivated Rabies Virus-Based Ebola Vaccine, FILORAB1, Adjuvanted With Glucopyranosyl Lipid A in Stable Emulsion Confers Complete Protection in Nonhuman Primate Challenge Models.Experimental Respiratory Infection of Marmosets (Callithrix jacchus) With Ebola Virus Kikwit.A vaccine against Ebola: Problems and opportunities.Ebola virus disease: history, epidemiology and outbreaks.Preventing the emergence of Ebola disease in unaffected countries: necessity of preparedness.
P2860
Q24289295-E4F6BE67-A67D-4006-AADE-C819F6A889AFQ24563097-650DBA5C-F5FA-4357-990D-2BD174E28338Q26775792-25624DA0-CB9D-45D5-8F98-D01657599EB1Q28051937-B9291277-5AAB-4DA9-9AA8-95679227DFAAQ30234637-3BE30B8A-39BB-44F0-BB72-0FB2A7CA9834Q30252022-949DA3B0-5F39-4B91-8DCE-3894F42DC17DQ30376138-01AF10FE-AFE3-4FE4-9502-F1A6512BDE41Q33758034-2374E27E-5793-42B4-AAB4-126F5AF130ACQ33825309-45D6AD6F-DE6B-4AC3-AE18-EC548DA3D8A1Q34435933-EEC8F2D4-B87B-4762-B9FE-976E5829A2F2Q34468847-3F4C7B16-7F6E-4F7E-B57E-C25156C82F69Q34540207-0EE9BE85-A608-4147-939A-50A72955577FQ34553720-312A167D-573A-4EE0-B99D-A7668CB23130Q35091692-846AE164-9A86-482C-937B-87A79AE2E228Q35160491-44A80BBB-E523-40CB-ACA2-245475F100D0Q35485277-AE1A7D26-23C0-45BC-89F9-9238A84375A2Q35917501-34AC9153-6827-4BCC-921B-E7209E095E47Q36043170-EB8920B3-B239-419B-BF44-5ECA8124D8C1Q36043199-71C0EC78-F181-4CEE-9951-99EB1503177BQ36043258-50422C68-06DE-4E09-B2D8-971928139CABQ36043269-E19E122E-75A6-45B2-8C58-987E1A9DCB5DQ36208191-897DECF6-F021-4DA9-BD79-1FA8C5EF690CQ36305916-3BFA3F7C-E0D6-40CA-AFE7-ADB2B2E7C347Q36363253-083C7981-9CCF-4BCA-B9E6-5349BF709AF7Q36474341-D20460C6-4C4C-4501-869C-D13B8A2D4C04Q36580268-B770E4C8-1AA4-4EDE-AB75-A6B611B1412DQ36611663-71A7725D-9AFE-4CE4-8A03-C880671F20FAQ36913606-04291853-5052-403D-AD20-0567FFA64239Q38363535-AA2D878D-4096-407C-BD78-1C1400AC96C2Q38500788-A463FC8F-4E94-4482-A69E-D28FD735C287Q38546746-37E4D9DC-44DF-419E-B985-D6ECFD5B66E6Q38674025-1D28FDA8-C7AD-4C1E-AFBF-BC21CC176AECQ38868057-AFCA22CF-6AE9-494E-BA72-D9EC83F0B4CCQ38868059-16DDB2B5-2FA2-4ED6-889B-25C62A9ADE9FQ40093846-46889460-E92B-493E-A080-143BD6A919D4Q40095257-5F99781F-7253-4834-A1B1-E4060C4B7141Q40145853-B486D0C6-6329-4863-B455-897D5C73A695Q40159211-70295522-587F-4DD0-9398-94EA41710F46Q40159475-2EA9C1ED-CB12-4B99-9E2A-081ACC739C03Q40178804-251D0A4D-30DD-487F-A093-1D89DF3B30F6
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Ebola virus vaccines: an overview of current approaches
@ast
Ebola virus vaccines: an overview of current approaches
@en
Ebola virus vaccines: an overview of current approaches
@nl
type
label
Ebola virus vaccines: an overview of current approaches
@ast
Ebola virus vaccines: an overview of current approaches
@en
Ebola virus vaccines: an overview of current approaches
@nl
prefLabel
Ebola virus vaccines: an overview of current approaches
@ast
Ebola virus vaccines: an overview of current approaches
@en
Ebola virus vaccines: an overview of current approaches
@nl
P2860
P3181
P1476
Ebola virus vaccines: an overview of current approaches
@en
P2860
P304
P3181
P356
10.1586/14760584.2014.885841
P407
P577
2014-04-01T00:00:00Z